which glp-1 is best for cardiovascular benefit medications are known their weight-loss effects, but fewer people may know that they could the heart too. In fact, Wegovy was approved by the FDA to reduce the risk Mechanisms by which GLP-1 agonists

Diabetes and Endocrinology 4537547

GI issues, gallbladder problems, lean mass loss, and long-term unknowns require thoughtful prescribing and monitoring

In the future, a multidimensional line of evidence is needed to clarify the source of GLP-1RA effects in IBD, including in vitro experiments to confirm direct actions, animal models designed to exclude metabolic interference, and clinical data adjusted for metabolic confounders

Clinical trials of GLP-1 receptor agonists have shown average reductions in daily energy intake of roughly 2030% during early treatment phases , reflecting the combined effects of increased satiety and reduced food preoccupation

While side effect profiles are similar, individual responses vary, and switching between similar medications sometimes improves tolerability

Note that the costs, dosages, and approved uses are U.S.-based